Health Economics Research Group (HERG)

The Health Economics Research Group (HERG) has developed an international reputation in health economics, building on strong foundations and a consistent strategy pursued over more than twenty-five years.

HERG's strategic focus is on the economic evaluation of a broad range of clinical and health service technologies and its dual aim is to provide applied, policy-relevant research whilst developing and refining methods to increase the rigour and relevance of such studies.

This strategy is highly relevant as economic evaluation begins to play more and more influential roles in international and national policies on the adoption and use of specific technologies.

HERG - REF 2014

News item
The Health Economics Research Group (HERG) is delighted to see its ratings reflecting increases in quality, growth and impact.

The Lancet: Leading experts call for an end to UK postcode lottery for liver disease treatment and detection

News item
In a major new Lancet Commission, led by Professor Roger Williams, Director of the Institute of Hepatology, London, UK, doctors and scientists from across the UK, including HERG, call for a radical scale up of liver disease treatment and detection facilities in the country, which has one of the worst rates of death from liver disease in Europe.

Page last updated: Friday 17 October 2014